NASDAQ
Tekla Life Sciences Investors (HQL) has a free cash flow growth of -22.05% as of Friday, May 29, 2026. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.